Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration

Journal of Physiology

Volumn 595, Issue 2, 2017, Pages 489-503

  Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

ageing; gut brain axis; stress

Indexed keywords

TRYPTOPHAN;

AGING; ALZHEIMER DISEASE; AMINO ACID METABOLISM; ARTICLE; AUTISM; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BRAIN DEVELOPMENT; COGNITIVE DEFECT; DISEASE ASSOCIATION; HUMAN; INTESTINE FLORA; MICROBIAL DIVERSITY; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SPECIES COMPOSITION; VAGUS NERVE; ANIMAL; BRAIN; DEGENERATIVE DISEASE; MENTAL DISEASE; MICROBIOLOGY; PHYSIOLOGY;

AGING; ANIMALS; BRAIN; GASTROINTESTINAL MICROBIOME; HUMANS; MENTAL DISORDERS; NEURODEGENERATIVE DISEASES;

EID: 85006340468     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP273106     Document Type: Article

References (164)

1. Alam MZ, Alam Q, Kamal MA, Abuzenadah AM & Haque A (2014). A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update. CNS Neurol Disord Drug Targets 13, 383–390.
2. Al-Asmakh M & Zadjali F (2015). Use of germ-free animal models in microbiota-related research. J Microbiol Biotechnol 25, 1583–1588.
3. Allin KH, Nielsen T & Pedersen O (2015). Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol 172, R167–R177.
4. Arrieta MC, Walter J, Finlay BB (2016). Human microbiota-associated mice: a model with challenges. Cell Host Microbe 19, 575–578.
5. Arentsen T, Raith H, Qian Y, Forssberg H & Diaz Heijtz R (2015). Host microbiota modulates development of social preference in mice. Microb Ecol Health Dis 26, 29719.
6. Aziz Q & Thompson DG (1998). Brain-gut axis in health and disease. Gastroenterology 114, 559–578.
7. Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, Li Y, Xia Y, Xie H, Zhong H, Khan MT, Zhang J, Li J, Xiao L, Al-Aama J, Zhang D, Lee YS, Kotowska D, Colding C, Tremaroli V, Yin Y, Bergman S, Xu X, Madsen L, Kristiansen K, Dahlgren J & Wang J (2015). Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 852.
8. Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM, Oltman CL, Azcarate-Peril MA, Kirby JR & Calarge CA (2015). Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry 5, e652.
9. Barrett E, Deshpandey AK, Ryan CA, Dempsey EM, Murphy B, O'Sullivan L, Watkins C, Ross RP, O'Toole PW, Fitzgerald GF & Stanton C (2015). The neonatal gut harbours distinct bifidobacterial strains. Arch Dis Child Fetal Neonatal Ed 100, F405–F410.
10. Barrett E, Guinane CM, Ryan CA, Dempsey EM, Murphy BP, O'Toole PW, Fitzgerald GF, Cotter PD, Ross RP & Stanton C (2013). Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants. Microbiologyopen 2, 215–225.
11. Bercik P, Collins SM & Verdu EF (2012). Microbes and the gut-brain axis. Neurogastroenterol Motil 24, 405–413.
12. Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF & Collins SM (2011a). The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141, 599–609.e3.
13. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, Berger B, Huizinga JD, Kunze W, McLean PG, Bergonzelli GE, Collins SM & Verdu EF (2011b). The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23, 1132–1139.
14. Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, Consolandi C, Quercia S, Scurti M, Monti D, Capri M, Brigidi P & Candela M (2016). Gut microbiota and extreme longevity. Curr Biol 26, 1480–1485.
15. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkila J, Monti D, Satokari R, Franceschi C, Brigidi P & De Vos W (2010). Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5, e10667.
16. Blaser MJ (2014). The microbiome revolution. J Clin Invest 124, 4162–4165.
17. Bordenstein SR & Theis KR (2015). Host biology in light of the microbiome: Ten principles of holobionts and hologenomes. PLoS Biol 13, e1002226.
18. Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF (2014). Treds Mol Med 20, 509–518.
19. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyas B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B & Pettersson S (2014). The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6, 263ra158.
20. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J & Cryan JF (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108, 16050–16055.
21. Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF & Costa-Mattioli M (2016). Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165, 1762–1775.
22. Canfora EE, Jocken JW & Blaak EE (2015). Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11, 577–591.
23. Chen JA, Penagarikano O, Belgard TG, Swarup V & Geschwind DH (2015). The emerging picture of autism spectrum disorder: genetics and pathology. Annu Rev Pathol 10, 111–144.
24. Chini B, Leonzino M, Braida D & Sala M (2014). Learning about oxytocin: pharmacologic and behavioral issues. Biol Psychiatry 76, 360–366.
25. Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, Pedersen LH & Vestergaard M (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309, 1696–1703.
26. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O'Connor M, Harnedy N, O'Connor K, Henry C, O'Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP & O'Toole PW (2011). Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 108, Suppl. 1, 4586–4591.
27. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O, Fitzgerald GF, Deane J, O'Connor M, Harnedy N, O'Connor K, O'Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP & O'Toole PW (2012). Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178–184.
28. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG & Cryan JF (2013). The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18, 666–673.
29. Clemente JC, Pehrsson EC, Blaser MJ, Sandhu K, Gao Z, Wang B, Magris M, Hidalgo G, Contreras M, Noya-Alarcón O, Lander O, McDonald J, Cox M, Walter J, Oh PL, Ruiz JF, Rodriguez S, Shen N, Song SJ, Metcalf J, Knight R, Dantas G & Dominguez-Bello MG (2015). The microbiome of uncontacted Amerindians. Sci Adv 1, e1500183.
30. Collado MC, Cernada M, Baüerl C, Vento M & Pérez-Martínez G (2012). Microbial ecology and host-microbiota interactions during early life stages. Gut Microbes 3, 352–365.
31. Collins SM, Surette M & Bercik P (2012). The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10, 735–742.
32. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ & Relman DA (2012). The application of ecological theory toward an understanding of the human microbiome. Science 336, 1255–1262.
33. Cryan JF & Dinan TG (2015). Gut microbiota: Microbiota and neuroimmune signalling – Metchnikoff to microglia. Nat Rev Gastroenterol Hepatol 12, 494–496.
34. Davey KJ, O’Mahony SM, Schellekens H, O’Sullivan O, Bienenstock J, Cotter PD, Dinan TG, Cryan JF (2012). Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl) 221, 155–169.
35. Davey KJ, Cotter PD, O'Sullivan O, Crispie F, Dinan TG, Cryan JF & O'Mahony SM (2013). Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry 3, e309.
36. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ & Turnbaugh PJ (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563.
37. De Palma G, Collins SM, Bercik P & Verdu EF (2014). The microbiota–gut–brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol 592, 2989–2997.
38. Desbonnet L, Clarke G, Shanahan F, Dinan TG & Cryan JF (2014). Microbiota is essential for social development in the mouse. Mol Psychiatry 19, 146–148.
39. Desbonnet L, Clarke G, Traplin A, O'Sullivan O, Crispie F, Moloney RD, Cotter PD, Dinan TG & Cryan JF (2015). Gut microbiota depletion from early adolescence in mice: Implications for brain and behavior. Brain Behav Immun 48, 165–173.
40. Desbonnet L, Garrett L, Clarke G, Bienenstock J & Dinan TG (2008). The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res 43, 164–174.
41. de Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD & Oozeer R (2014). Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 37, 197–206.
42. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, Hibberd ML, Forssberg H & Pettersson S (2011). Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108, 3047–3052.
43. Dinan TG, Borre YE & Cryan JF (2014). Genomics of schizophrenia: time to consider the gut microbiome? Mol Psychiatry 19, 1252–1257.
44. Dinan TG, Stilling RM, Stanton C, Cryan JF (2015). Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res 63, 1–9.
45. Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F & Keeling PW (2006). Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130, 304–311.
46. Distrutti E, O'Reilly JA, McDonald C, Cipriani S, Renga B, Lynch MA & Fiorucci S (2014). Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS One 9, e106503.
47. Dobbs SM, Dobbs RJ, Weller C, Charlett A, Augustin A, Taylor D, Ibrahim MA & Bjarnason I (2016). Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota. J Neurovirol 22, 22–32.
48. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N & Knight R (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107, 11971–11975.
49. Donnet-Hughes A, Perez PF, Dore J, Leclerc M, Levenez F, Benyacoub J, Serrant P, Segura-Roggero I & Schiffrin EJ (2010). Potential role of the intestinal microbiota of the mother in neonatal immune education. Proc Nutr Soc 69, 407–415.
50. El Aidy S, Dinan TG, Cryan JF (2014). Immune modulation of the brain-gut-microbiota axis. Front Microbiol 5, 146.
51. El Aidy S, Dinan TG & Cryan JF (2015). Gut microbiota: The conductor in the orchestra of immune-neuroendocrine communication. Clin Ther 37, 954–967.
52. Erdman SE & Poutahidis T (2014). Probiotic ‘glow of health’: it's more than skin deep. Benef Microbes 5, 109–119.
53. Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermohlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I & Prinz M (2015). Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18, 965–977.
54. Esposito P, Chandler N, Kandere K, Basu S, Jacobson S, Connolly R, Tutor D & Theoharides TC (2002). Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 303, 1061–1066.
55. Faith JJ, Ahern PP, Ridaura VK, Cheng J & Gordon JI (2014). Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med 6, 220ra11.
56. Farhadi A, Banan A, Fields J & Keshavarzian A (2003). Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 18, 479–497.
57. Fasano A (2012). Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol 10, 1096–1100.
58. Felice VD, Quigley EM, Sullivan AM, O'Keeffe GW & O'Mahony SM (2016). Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 27, 1–8.
59. Foster JA, Lyte M, Meyer E & Cryan JF (2016). Gut microbiota and brain function: An evolving field in neuroscience. Int J Neuropsychopharmacol 19, pyv114.
60. Gacias M, Gaspari S, Santos PM, Tamburini S, Andrade M, Zhang F, Shen N, Tolstikov V, Kiebish MA, Dupree JL, Zachariou V, Clemente JC & Casaccia P (2016). Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior. Elife 5, e13442.
61. Galland L (2014). The gut microbiome and the brain. J Med Food 17, 1261–1272.
62. Gareau MG (2014). Microbiota-gut-brain axis and cognitive function. Adv Exp Med Biol 817, 357–371.
63. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, Macqueen G & Sherman PM (2011). Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60, 307–317.
64. Gilbert JA, Quinn RA, Debelius J, Xu ZZ, Morton J, Garg N, Jansson JK, Dorrestein PC & Knight R (2016). Microbiome-wide association studies link dynamic microbial consortia to disease. Nature 535, 94–103.
65. Glimstedt G (1959). The germfree animal as a research tool. Ann N Y Acad Sci 78, 281–284.
66. Goedert JJ, Hua X, Yu G & Shi J (2014). Diversity and composition of the adult fecal microbiome associated with history of cesarean birth or appendectomy: Analysis of the American Gut Project. EBioMedicine 1, 167–172.
67. Grace E, Shaw C, Whelan K & Andreyev HJ (2013). Review article: small intestinal bacterial overgrowth – prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 38, 674–688.
68. Grenham S, Clarke G, Cryan JF & Dinan TG (2011). Brain-gut-microbe communication in health and disease. Front Physiol 2, 94.
69. Grover M & Kashyap PC (2014). Germ-free mice as a model to study effect of gut microbiota on host physiology. Neurogastroenterol Motil 26, 745–748.
70. Gustafsson B (1946). Germ-free rearing of rats. Acta Anat (Basel) 2, 376–391.
71. Harach T, Marungruang N, Dutilleul N, Cheatham V, Mc Coy KD, Neher JJ, Jucker M, Fåk F, Lasser T, Bolmont T (2015). Reduction of Alzheimer's disease beta-amyloid pathology in the absence of gut microbiota. Available at: https://arxiv.org/ftp/arxiv/papers/1509/1509.02273.pdf.
72. He C, Shan Y & Song W (2015). Targeting gut microbiota as a possible therapy for diabetes. Nutr Res 35, 361–367.
73. Hinde K & Lewis ZT (2015). MICROBIOTA. Mother's littlest helpers. Science 348, 1427–1428.
74. Hoban AE, Stilling RM, Ryan FJ, Shanahan F, Dinan TG, Claesson MJ, Clarke G & Cryan JF (2016). Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry 6, e774.
75. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH & Mazmanian SK (2013). Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451–1463.
76. Janak PH & Tye KM (2015). From circuits to behaviour in the amygdala. Nature 517, 284–292.
77. Johansson ME, Sjovall H & Hansson GC (2013). The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 10, 352–361.
78. Jyothi HJ, Vidyadhara DJ, Mahadevan A, Philip M, Parmar SK, Manohari SG, Shankar SK, Raju TR & Alladi PA (2015). Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta. Neurobiol Aging 36, 3321–3333.
79. Kamada N, Seo SU, Chen GY & Nunez G (2013). Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13, 321–335.
80. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G & Hyland NP (2015). Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci 9, 392.
81. Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E & Shannon KM (2015). Colonic bacterial composition in Parkinson's disease. Mov Disord 30, 1351–1360.
82. Khodaie-Ardakani MR, Mirshafiee O, Farokhnia M, Tajdini M, Hosseini SM, Modabbernia A, Rezaei F, Salehi B, Yekehtaz H, Ashrafi M, Tabrizi M & Akhondzadeh S (2014). Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study. Psychiatry Res 215, 540–546.
83. Koh A, De Vadder F, Kovatcheva-Datchary P & Backhed F (2016). From dietary fibre to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332–1345.
84. Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, Lefkowitz A, McColl G, Goldstein LE, Tanzi RE & Moir RD (2016). Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med 8, 340ra372.
85. Lankelma JM, Nieuwdorp M, de Vos WM & Wiersinga WJ (2015). The gut microbiota in internal medicine: implications for health and disease. Neth J Med 73, 61–68.
86. Leach J (2013). Gut microbiota: Please pass the microbes. Nature 504, 33.
87. LeDoux J (2007). The amygdala. Curr Biol 17, R868–874.
88. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH & Kipnis J (2015). Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337–341.
89. Lu K, Mahbub R & Fox JG (2015). Xenobiotics: Interaction with the intestinal microflora. ILAR J 56, 218–227.
90. Luczynski P, McVey Neufeld KA, Oriach CS, Clarke G, Dinan TG & Cryan JF (2016a). Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int J Neuropsychopharmacol 19, pyw020.
91. Luczynski P, Whelan SO, O'Sullivan C, Clarke G, Shanahan F, Dinan TG & Cryan JF (2016b). Adult microbiota-deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus. Eur J Neurosci (in press; DOI: 10.1111/ejn.13291).
92. Lynch MA (2004). Long-term potentiation and memory. Physiol Rev 84, 87–136.
93. Lynch DB, Jeffery IB, Cusack S, O'Connor EM & O'Toole PW (2015). Diet-microbiota-health interactions in older subjects: implications for healthy aging. Interdiscip Top Gerontol 40, 141–154.
94. Lyte M (2013). Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog 9, e1003726.
95. Lyte M (2014). Microbial endocrinology: Host-microbiota neuroendocrine interactions influencing brain and behavior. Gut Microbes 5, 381–389.
96. Mackowiak PA (2013). Recycling Metchnikoff: probiotics, the intestinal microbiome and the quest for long life. Front Public Health 1, 52.
97. Martinez I, Stegen JC, Maldonado-Gomez MX, Eren AM, Siba PM, Greenhill AR & Walter J (2015). The gut microbiota of rural papua new guineans: composition, diversity patterns, and ecological processes. Cell Rep 11, 527–538.
98. Matamoros S, Gras-Leguen C, Le Vacon F, Potel G & de La Cochetiere MF (2013). Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 21, 167–173.
99. Mayer EA (2011). Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12, 453–466.
100. Mayer EA, Knight R, Mazmanian SK, Cryan JF & Tillisch K (2014a). Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 34, 15490–15496.
101. Mayer EA, Padua D & Tillisch K (2014b). Altered brain-gut axis in autism: comorbidity or causative mechanisms? Bioessays 36, 933–939.
102. Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, Musch MW, Liao F, Ward JF, Holtzman DM, Chang EB, Tanzi RE & Sisodia SS (2016). Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci Rep 6, 30028.
103. Miraglia F, Betti L, Palego L & Giannaccini G (2015). Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge. Cent Nerv Syst Agents Med Chem 15, 109–116.
104. Miyamoto S, Miyake N, Jarskog LF, Fleischhacker WW & Lieberman JA (2012). Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry 17, 1206–1227.
105. Moghaddam B & Javitt D (2012). From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37, 4–15.
106. hi monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep 15, 1945–1956.
107. Moloney RD, Desbonnet L, Clarke G, Dinan TG & Cryan JF (2014). The microbiome: stress, health and disease. Mamm Genome 25, 49–74.
108. Moloney RD, Dinan TG & Cryan JF (2015). Stress & the microbiota-gut-brain axis in visceral pain. Psychoneuroendocrinology 61, 8.
109. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M & Zlokovic BV (2015). Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296–302.
110. Morgan AP, Crowley JJ, Nonneman RJ, Quackenbush CR, Miller CN, Ryan AK, Bogue MA, Paredes SH, Yourstone S, Carroll IM, Kawula TH, Bower MA, Sartor RB & Sullivan PF (2014). The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS One 9, e115225.
111. Mosconi MW, Cody-Hazlett H, Poe MD, Gerig G, Gimpel-Smith R & Piven J (2009). Longitudinal study of amygdala volume and joint attention in 2- to 4-year-old children with autism. Arch Gen Psychiatry 66, 509–516.
112. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J & Crawley JN (2004). Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 3, 287–302.
113. Neufeld KM, Kang N, Bienenstock J & Foster JA (2011). Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 23, 255–264, e119.
114. Nguyen TL, Vieira-Silva S, Liston A & Raes J (2015). How informative is the mouse for human gut microbiota research? Dis Model Mech 8, 1–16.
115. Ogbonnaya ES, Clarke G, Shanahan F, Dinan TG, Cryan JF & O'Leary OF (2015). Adult hippocampal neurogenesis is regulated by the microbiome. Biol Psychiatry 78, e7–9.
116. O’Leary OF, Cryan JF (2014). A ventral view on antidepressant action: roles for adult hippocampal neurogenesis along the dorsoventral axis. Trends in Pharmacological Sciences 35, 675–687.
117. Olofsson PS, Rosas-Ballina M, Levine YA & Tracey KJ (2012). Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev 248, 188–204.
118. O'Mahony SM, Clarke G, Borre YE, Dinan TG & Cryan JF (2015a). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277, 32–48.
119. O'Mahony SM, Clarke G, Dinan TG & Cryan JF (2015b). Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle? Neuroscience (in press; DOI: 10.1016/j.neuroscience.2015.09.068).
120. O'Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, Woznicki J, Hyland NP, Shanahan F, Quigley EM, Marchesi JR, O'Toole PW, Dinan TG & Cryan JF (2014). Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience 277, 885–901.
121. O'Mahony SM, Hyland NP, Dinan TG & Cryan JF (2011). Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl) 214, 71–88.
122. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF & Dinan TG (2009). Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illesses. Biol Psychiatry 65, 263–267.
123. O'Toole PW & Jeffery IB (2015). Gut microbiota and aging. Science 350, 1214–1215.
124. Paul B, Barnes S, Demark-Wahnefried W, Morrow C, Salvador C, Skibola C & Tollefsbol TO (2015). Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin Epigenetics 7, 112.
125. Prenderville JA, Kennedy PJ, Dinan TG, Cryan JF (2015). Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neurosci 38, 13–25.
126. Pyndt Jorgensen B, Krych L, Pedersen TB, Plath N, Redrobe JP, Hansen AK, Nielsen DS, Pedersen CS, Larsen C & Sorensen DB (2015). Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia. Physiol Behav 141, 32–39.
127. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J-M, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD & Wang J (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65.
128. Rampelli S, Schnorr SL, Consolandi C, Turroni S, Severgnini M, Peano C, Brigidi P, Crittenden AN, Henry AG & Candela M (2015). Metagenome sequencing of the Hadza hunter-gatherer gut microbiota. Curr Biol 25, 1682–1693.
129. Rhee SH, Pothoulakis C & Mayer EA (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol hepatol 6, 306–314.
130. Rondanelli M, Giacosa A, Faliva MA, Perna S, Allieri F & Castellazzi AM (2015). Review on microbiota and effectiveness of probiotics use in older. World J Clin Cases 3, 156–162.
131. Rosenfeld CS (2015). Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos 43, 1557–1571.
132. Sampson TR & Mazmanian SK (2015). Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17, 565–576.
133. Sankar SA, Lagier JC, Pontarotti P, Raoult D & Fournier PE (2015). The human gut microbiome, a taxonomic conundrum. Syst Appl Microbiol 38, 276–286.
134. Savignac HM, Tramullas M, Kiely B, Dinan TG & Cryan JF (2015). Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res 287, 59–72.
135. Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L & Gasbarrini A (2012). The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol 46, Suppl., S12–17.
136. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K & Auvinen P (2015). Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 30, 350–358.
137. Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G, Turroni S, Biagi E, Peano C, Severgnini M, Fiori J, Gotti R, De Bellis G, Luiselli D, Brigidi P, Mabulla A, Marlowe F, Henry AG & Crittenden AN (2014). Gut microbiome of the Hadza hunter-gatherers. Nat Commun 5, 3654.
138. Schumann CM & Amaral DG (2006). Stereological analysis of amygdala neuron number in autism. J Neurosci 26, 7674–7679.
139. Scott LV, Clarke G & Dinan TG (2013). The brain-gut axis: a target for treating stress-related disorders. Mod Trends Pharmacopsychiatri 28, 90–99.
140. Sender R, Fuchs S & Milo R (2016). Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164, 337–340.
141. Shen HH (2015). News feature: Microbes on the mind. Proc Natl Acad Sci USA 112, 9143–9145.
142. Sommer F & Backhed F (2013). The gut microbiota – masters of host development and physiology. Nat Rev Microbiol 11, 227–238.
143. Sommer F & Backhed F (2016). Know your neighbor: Microbiota and host epithelial cells interact locally to control intestinal function and physiology. Bioessays 38, 455–464.
144. Son JS, Zheng LJ, Rowehl LM, Tian X, Zhang Y, Zhu W, Litcher-Kelly L, Gadow KD, Gathungu G, Robertson CE, Ir D, Frank DN & Li E (2015). Comparison of fecal microbiota in children with autism spectrum disorders and neurotypical siblings in the Simons Simplex Collection. PLoS One 10, e0137725.
145. Sonnenberg GF & Artis D (2012). Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 37, 601–610.
146. Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS & Sonnenburg JL (2016). Diet-induced extinctions in the gut microbiota compound over generations. Nature 529, 212–215.
147. Spanogiannopoulos P, Bess EN, Carmody RN & Turnbaugh PJ (2016). The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol 14, 273–287.
148. Stilling RM, Dinan TG & Cryan JF (2014). Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav 13, 69–86.
149. Stilling RM, Ryan FJ, Hoban AE, Shanahan F, Clarke G, Claesson MJ, Dinan TG & Cryan JF (2015). Microbes & neurodevelopment – Absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala. Brain Behav Immun 50, 209–220.
150. Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG & Cryan JF (2016). The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochem Int 99, 110–132.
151. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C & Koga Y (2004). Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. J Physiol 558, 263–275.
152. Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P & Sorensen HT (2015). Vagotomy and subsequent risk of Parkinson's disease. Ann Neurol 78, 522–529.
153. Tillisch K (2014). The effects of gut microbiota on CNS function in humans. Gut Microbes 5, 404–410.
154. Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K & Ostatnikova D (2015). Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 138, 179–187.
155. Vandenplas Y (2015). Healthy gut microbiota and long term health. Benef Microbes 6, 173–179.
156. Voreades N, Kozil A & Weir TL (2014). Diet and the development of the human intestinal microbiome. Front Microbiol 5, 494.
157. Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG & Stanton C (2014). Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol 817, 221–239.
158. Wang Y & Kasper LH (2014). The role of microbiome in central nervous system disorders. Brain Behav Immun 38, 1–12.
159. Yang I, Corwin EJ, Brennan PA, Jordan S, Murphy JR & Dunlop A (2016). The infant microbiome: Implications for infant health and neurocognitive development. Nurs Res 65, 76–88.
160. Yassour M, Vatanen T, Siljander H, Hamalainen AM, Harkonen T, Ryhanen SJ, Franzosa EA, Vlamakis H, Huttenhower C, Gevers D, Lander ES, Knip M, Group DS & Xavier RJ (2016). Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 8, 343ra381.
161. Yatawara CJ, Einfeld SL, Hickie IB, Davenport TA & Guastella AJ (2016). The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry 21, 1225–1231.
162. Young LJ & Pfaff DW (2014). Sex differences in neurological and psychiatric disorders. Front Neuroendocrinol 35, 253–254.
163. Zapata HJ & Quagliarello VJ (2015). The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc 63, 776–781.
164. Ziats MN, Grosvenor LP & Rennert OM (2015). Functional genomics of human brain development and implications for autism spectrum disorders. Transl Psychiatry 5, e665.